ID DMRT3_HUMAN Reviewed; 472 AA. AC Q9NQL9; Q7LA03; Q7LCH8; Q96SC7; Q9NRQ9; DT 20-FEB-2007, integrated into UniProtKB/Swiss-Prot. DT 01-OCT-2000, sequence version 1. DT 27-MAR-2024, entry version 158. DE RecName: Full=Doublesex- and mab-3-related transcription factor 3; GN Name=DMRT3; Synonyms=DMRTA3; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15164053; DOI=10.1038/nature02465; RA Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L., RA Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R., RA Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S., RA Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K., RA Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y., RA Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C., RA Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E., RA Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M., RA Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J., RA Frankish A., Frankland J.A., French L., Fricker D.G., Garner P., RA Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S., RA Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E., RA Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D., RA Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E., RA Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K., RA Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S., RA Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J., RA Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E., RA McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V., RA Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S., RA Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K., RA Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J., RA Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., RA West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L., RA Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M., RA Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J., RA Dunham I.; RT "DNA sequence and analysis of human chromosome 9."; RL Nature 429:369-374(2004). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Colon; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [3] RP NUCLEOTIDE SEQUENCE [MRNA] OF 46-169. RC TISSUE=Testis; RX PubMed=11863363; DOI=10.1006/geno.2002.6711; RA Ottolenghi C., Fellous M., Barbieri M., McElreavey K.; RT "Novel paralogy relations among human chromosomes support a link between RT the phylogeny of doublesex-related genes and the evolution of sex RT determination."; RL Genomics 79:333-343(2002). RN [4] RP NUCLEOTIDE SEQUENCE [MRNA] OF 130-472, TISSUE SPECIFICITY, AND RP DEVELOPMENTAL STAGE. RX PubMed=10729223; DOI=10.1006/geno.2000.6121; RA Ottolenghi C., Veitia R., Quintana-Murci L., Torchard D., Scapoli L., RA Souleyreau-Therville N., Beckmann J., Fellous M., McElreavey K.; RT "The region on 9p associated with 46,XY sex reversal contains several RT transcripts expressed in the urogenital system and a novel doublesex- RT related domain."; RL Genomics 64:170-178(2000). RN [5] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma; RX PubMed=18669648; DOI=10.1073/pnas.0805139105; RA Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., RA Elledge S.J., Gygi S.P.; RT "A quantitative atlas of mitotic phosphorylation."; RL Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). RN [6] RP INTERACTION WITH UBIQUITIN, AND DOMAIN. RX PubMed=33021200; DOI=10.7554/elife.59614; RA Bayer E.A., Stecky R.C., Neal L., Katsamba P.S., Ahlsen G., Balaji V., RA Hoppe T., Shapiro L., Oren-Suissa M., Hobert O.; RT "Ubiquitin-dependent regulation of a conserved DMRT protein controls RT sexually dimorphic synaptic connectivity and behavior."; RL Elife 9:0-0(2020). CC -!- FUNCTION: Probable transcription factor that plays a role in CC configuring the spinal circuits controlling stride in vertebrates. CC Involved in neuronal specification within specific subdivision of CC spinal cord neurons and in the development of a coordinated locomotor CC network controlling limb movements. May regulate transcription during CC sexual development (By similarity). {ECO:0000250}. CC -!- SUBUNIT: May homodimerize. {ECO:0000269|PubMed:33021200}. CC -!- INTERACTION: CC Q9NQL9; Q9ULX6: AKAP8L; NbExp=3; IntAct=EBI-9679045, EBI-357530; CC Q9NQL9; Q86U10: ASPG; NbExp=3; IntAct=EBI-9679045, EBI-19946665; CC Q9NQL9; Q86V38: ATN1; NbExp=3; IntAct=EBI-9679045, EBI-11954292; CC Q9NQL9; P61421: ATP6V0D1; NbExp=3; IntAct=EBI-9679045, EBI-954063; CC Q9NQL9; O95273: CCNDBP1; NbExp=3; IntAct=EBI-9679045, EBI-748961; CC Q9NQL9; Q9H5F2: CFAP68; NbExp=3; IntAct=EBI-9679045, EBI-718615; CC Q9NQL9; A8MQ03: CYSRT1; NbExp=3; IntAct=EBI-9679045, EBI-3867333; CC Q9NQL9; Q13643: FHL3; NbExp=3; IntAct=EBI-9679045, EBI-741101; CC Q9NQL9; Q5TD97: FHL5; NbExp=3; IntAct=EBI-9679045, EBI-750641; CC Q9NQL9; O15353: FOXN1; NbExp=3; IntAct=EBI-9679045, EBI-11319000; CC Q9NQL9; O43559: FRS3; NbExp=3; IntAct=EBI-9679045, EBI-725515; CC Q9NQL9; Q86YR5-3: GPSM1; NbExp=3; IntAct=EBI-9679045, EBI-10261098; CC Q9NQL9; P28799: GRN; NbExp=3; IntAct=EBI-9679045, EBI-747754; CC Q9NQL9; O75031: HSF2BP; NbExp=3; IntAct=EBI-9679045, EBI-7116203; CC Q9NQL9; Q0VD86: INCA1; NbExp=6; IntAct=EBI-9679045, EBI-6509505; CC Q9NQL9; O75525: KHDRBS3; NbExp=3; IntAct=EBI-9679045, EBI-722504; CC Q9NQL9; Q5T749: KPRP; NbExp=5; IntAct=EBI-9679045, EBI-10981970; CC Q9NQL9; Q15323: KRT31; NbExp=6; IntAct=EBI-9679045, EBI-948001; CC Q9NQL9; O76011: KRT34; NbExp=3; IntAct=EBI-9679045, EBI-1047093; CC Q9NQL9; Q92764: KRT35; NbExp=3; IntAct=EBI-9679045, EBI-1058674; CC Q9NQL9; O76013-2: KRT36; NbExp=3; IntAct=EBI-9679045, EBI-11958506; CC Q9NQL9; O76015: KRT38; NbExp=3; IntAct=EBI-9679045, EBI-1047263; CC Q9NQL9; Q6A162: KRT40; NbExp=6; IntAct=EBI-9679045, EBI-10171697; CC Q9NQL9; Q07627: KRTAP1-1; NbExp=3; IntAct=EBI-9679045, EBI-11959885; CC Q9NQL9; Q8IUG1: KRTAP1-3; NbExp=3; IntAct=EBI-9679045, EBI-11749135; CC Q9NQL9; Q9BYS1: KRTAP1-5; NbExp=3; IntAct=EBI-9679045, EBI-11741292; CC Q9NQL9; P60409: KRTAP10-7; NbExp=3; IntAct=EBI-9679045, EBI-10172290; CC Q9NQL9; P60410: KRTAP10-8; NbExp=6; IntAct=EBI-9679045, EBI-10171774; CC Q9NQL9; P60411: KRTAP10-9; NbExp=6; IntAct=EBI-9679045, EBI-10172052; CC Q9NQL9; Q3LI72: KRTAP19-5; NbExp=3; IntAct=EBI-9679045, EBI-1048945; CC Q9NQL9; Q9BYR9: KRTAP2-4; NbExp=3; IntAct=EBI-9679045, EBI-14065470; CC Q9NQL9; Q9BYR8: KRTAP3-1; NbExp=5; IntAct=EBI-9679045, EBI-9996449; CC Q9NQL9; Q9BYR6: KRTAP3-3; NbExp=3; IntAct=EBI-9679045, EBI-3957694; CC Q9NQL9; Q6L8G8: KRTAP5-7; NbExp=3; IntAct=EBI-9679045, EBI-11987425; CC Q9NQL9; P26371: KRTAP5-9; NbExp=3; IntAct=EBI-9679045, EBI-3958099; CC Q9NQL9; Q3LI66: KRTAP6-2; NbExp=3; IntAct=EBI-9679045, EBI-11962084; CC Q9NQL9; Q9BYQ4: KRTAP9-2; NbExp=3; IntAct=EBI-9679045, EBI-1044640; CC Q9NQL9; Q9BYQ3: KRTAP9-3; NbExp=3; IntAct=EBI-9679045, EBI-1043191; CC Q9NQL9; Q14847-2: LASP1; NbExp=3; IntAct=EBI-9679045, EBI-9088686; CC Q9NQL9; P25791-3: LMO2; NbExp=3; IntAct=EBI-9679045, EBI-11959475; CC Q9NQL9; Q99750: MDFI; NbExp=6; IntAct=EBI-9679045, EBI-724076; CC Q9NQL9; Q6FHY5: MEOX2; NbExp=3; IntAct=EBI-9679045, EBI-16439278; CC Q9NQL9; Q9UJV3-2: MID2; NbExp=6; IntAct=EBI-9679045, EBI-10172526; CC Q9NQL9; Q5JR59: MTUS2; NbExp=3; IntAct=EBI-9679045, EBI-742948; CC Q9NQL9; Q5JR59-3: MTUS2; NbExp=3; IntAct=EBI-9679045, EBI-11522433; CC Q9NQL9; Q8TDC0: MYOZ3; NbExp=3; IntAct=EBI-9679045, EBI-5662487; CC Q9NQL9; Q8NI38: NFKBID; NbExp=3; IntAct=EBI-9679045, EBI-10271199; CC Q9NQL9; P0CG21: NHLRC4; NbExp=3; IntAct=EBI-9679045, EBI-12868744; CC Q9NQL9; Q7Z3S9: NOTCH2NLA; NbExp=3; IntAct=EBI-9679045, EBI-945833; CC Q9NQL9; P0DPK4: NOTCH2NLC; NbExp=3; IntAct=EBI-9679045, EBI-22310682; CC Q9NQL9; O43482: OIP5; NbExp=3; IntAct=EBI-9679045, EBI-536879; CC Q9NQL9; Q99471: PFDN5; NbExp=3; IntAct=EBI-9679045, EBI-357275; CC Q9NQL9; Q9H8W4: PLEKHF2; NbExp=3; IntAct=EBI-9679045, EBI-742388; CC Q9NQL9; O15162: PLSCR1; NbExp=3; IntAct=EBI-9679045, EBI-740019; CC Q9NQL9; Q9GZV8: PRDM14; NbExp=3; IntAct=EBI-9679045, EBI-3957793; CC Q9NQL9; P86480: PRR20D; NbExp=3; IntAct=EBI-9679045, EBI-12754095; CC Q9NQL9; P25788: PSMA3; NbExp=3; IntAct=EBI-9679045, EBI-348380; CC Q9NQL9; P61289: PSME3; NbExp=3; IntAct=EBI-9679045, EBI-355546; CC Q9NQL9; Q93062: RBPMS; NbExp=3; IntAct=EBI-9679045, EBI-740322; CC Q9NQL9; Q04864: REL; NbExp=3; IntAct=EBI-9679045, EBI-307352; CC Q9NQL9; Q04864-2: REL; NbExp=3; IntAct=EBI-9679045, EBI-10829018; CC Q9NQL9; Q8HWS3: RFX6; NbExp=3; IntAct=EBI-9679045, EBI-746118; CC Q9NQL9; Q9BVN2: RUSC1; NbExp=3; IntAct=EBI-9679045, EBI-6257312; CC Q9NQL9; P21673: SAT1; NbExp=6; IntAct=EBI-9679045, EBI-711613; CC Q9NQL9; Q99932-2: SPAG8; NbExp=3; IntAct=EBI-9679045, EBI-11959123; CC Q9NQL9; P15884: TCF4; NbExp=3; IntAct=EBI-9679045, EBI-533224; CC Q9NQL9; Q08117-2: TLE5; NbExp=3; IntAct=EBI-9679045, EBI-11741437; CC Q9NQL9; Q13077: TRAF1; NbExp=3; IntAct=EBI-9679045, EBI-359224; CC Q9NQL9; P36406: TRIM23; NbExp=3; IntAct=EBI-9679045, EBI-740098; CC Q9NQL9; P14373: TRIM27; NbExp=6; IntAct=EBI-9679045, EBI-719493; CC Q9NQL9; Q15654: TRIP6; NbExp=3; IntAct=EBI-9679045, EBI-742327; CC Q9NQL9; Q86WV8: TSC1; NbExp=3; IntAct=EBI-9679045, EBI-12806590; CC Q9NQL9; Q6DKK2: TTC19; NbExp=3; IntAct=EBI-9679045, EBI-948354; CC Q9NQL9; Q8TF42: UBASH3B; NbExp=3; IntAct=EBI-9679045, EBI-1380492; CC Q9NQL9; Q70EL1-9: USP54; NbExp=3; IntAct=EBI-9679045, EBI-11975223; CC Q9NQL9; Q9NZC7-5: WWOX; NbExp=3; IntAct=EBI-9679045, EBI-12040603; CC Q9NQL9; P08048: ZFY; NbExp=3; IntAct=EBI-9679045, EBI-12239601; CC Q9NQL9; Q9H0C1: ZMYND12; NbExp=3; IntAct=EBI-9679045, EBI-12030590; CC Q9NQL9; Q7Z4V0: ZNF438; NbExp=3; IntAct=EBI-9679045, EBI-11962468; CC -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00070}. CC -!- TISSUE SPECIFICITY: Expressed in testis. {ECO:0000269|PubMed:10729223}. CC -!- DEVELOPMENTAL STAGE: Expressed in 4 to 5 weeks embryos. CC {ECO:0000269|PubMed:10729223}. CC -!- DOMAIN: DMA domain interacts with ubiquitin. CC {ECO:0000269|PubMed:33021200}. CC -!- MISCELLANEOUS: DMRT3 is a marker for a subset of spinal cord neurons CC (dI6). CC -!- SIMILARITY: Belongs to the DMRT family. {ECO:0000305}. CC -!- WEB RESOURCE: Name=Protein Spotlight; Note=A gait on the wildside CC - Issue 154 of November 2013; CC URL="https://web.expasy.org/spotlight/back_issues/154/"; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AL136365; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BC113584; AAI13585.1; -; mRNA. DR EMBL; BC117245; AAI17246.1; -; mRNA. DR EMBL; AJ301581; CAC37947.1; -; mRNA. DR EMBL; AF193873; AAF78892.1; -; mRNA. DR CCDS; CCDS6443.1; -. DR RefSeq; NP_067063.1; NM_021240.3. DR AlphaFoldDB; Q9NQL9; -. DR SMR; Q9NQL9; -. DR BioGRID; 121844; 88. DR IntAct; Q9NQL9; 79. DR MINT; Q9NQL9; -. DR STRING; 9606.ENSP00000190165; -. DR GlyGen; Q9NQL9; 1 site, 1 O-linked glycan (1 site). DR iPTMnet; Q9NQL9; -. DR PhosphoSitePlus; Q9NQL9; -. DR BioMuta; DMRT3; -. DR DMDM; 74752905; -. DR MassIVE; Q9NQL9; -. DR PaxDb; 9606-ENSP00000190165; -. DR PeptideAtlas; Q9NQL9; -. DR ProteomicsDB; 82163; -. DR Antibodypedia; 23783; 175 antibodies from 24 providers. DR DNASU; 58524; -. DR Ensembl; ENST00000190165.3; ENSP00000190165.2; ENSG00000064218.5. DR GeneID; 58524; -. DR KEGG; hsa:58524; -. DR MANE-Select; ENST00000190165.3; ENSP00000190165.2; NM_021240.4; NP_067063.1. DR UCSC; uc003zgw.3; human. DR AGR; HGNC:13909; -. DR CTD; 58524; -. DR DisGeNET; 58524; -. DR GeneCards; DMRT3; -. DR HGNC; HGNC:13909; DMRT3. DR HPA; ENSG00000064218; Tissue enhanced (choroid plexus, parathyroid gland, testis). DR MalaCards; DMRT3; -. DR MIM; 614754; gene. DR neXtProt; NX_Q9NQL9; -. DR OpenTargets; ENSG00000064218; -. DR Orphanet; 251510; 46,XY partial gonadal dysgenesis. DR PharmGKB; PA27383; -. DR VEuPathDB; HostDB:ENSG00000064218; -. DR eggNOG; KOG3815; Eukaryota. DR GeneTree; ENSGT00940000160420; -. DR HOGENOM; CLU_052449_1_0_1; -. DR InParanoid; Q9NQL9; -. DR OMA; RWASEPQ; -. DR OrthoDB; 2915919at2759; -. DR PhylomeDB; Q9NQL9; -. DR TreeFam; TF317837; -. DR PathwayCommons; Q9NQL9; -. DR SignaLink; Q9NQL9; -. DR BioGRID-ORCS; 58524; 10 hits in 1164 CRISPR screens. DR ChiTaRS; DMRT3; human. DR GenomeRNAi; 58524; -. DR Pharos; Q9NQL9; Tbio. DR PRO; PR:Q9NQL9; -. DR Proteomes; UP000005640; Chromosome 9. DR RNAct; Q9NQL9; Protein. DR Bgee; ENSG00000064218; Expressed in male germ line stem cell (sensu Vertebrata) in testis and 77 other cell types or tissues. DR ExpressionAtlas; Q9NQL9; baseline and differential. DR GO; GO:0000785; C:chromatin; ISA:NTNU_SB. DR GO; GO:0005634; C:nucleus; IBA:GO_Central. DR GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISA:NTNU_SB. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central. DR GO; GO:1990837; F:sequence-specific double-stranded DNA binding; IDA:ARUK-UCL. DR GO; GO:0007628; P:adult walking behavior; IEA:Ensembl. DR GO; GO:0046661; P:male sex differentiation; IBA:GO_Central. DR GO; GO:0042487; P:regulation of odontogenesis of dentin-containing tooth; IEA:Ensembl. DR GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central. DR GO; GO:0007548; P:sex differentiation; NAS:UniProtKB. DR GO; GO:0019226; P:transmission of nerve impulse; IEA:Ensembl. DR GO; GO:0021521; P:ventral spinal cord interneuron specification; IEA:Ensembl. DR CDD; cd14419; CUE_DMA_DMRTA3; 1. DR Gene3D; 4.10.1040.10; DM DNA-binding domain; 1. DR InterPro; IPR001275; DM_DNA-bd. DR InterPro; IPR036407; DM_DNA-bd_sf. DR InterPro; IPR005173; DMA. DR InterPro; IPR026607; DMRT. DR InterPro; IPR009060; UBA-like_sf. DR PANTHER; PTHR12322; DOUBLESEX AND MAB-3 RELATED TRANSCRIPTION FACTOR DMRT; 1. DR PANTHER; PTHR12322:SF120; DOUBLESEX- AND MAB-3-RELATED TRANSCRIPTION FACTOR 3; 1. DR Pfam; PF00751; DM; 1. DR Pfam; PF03474; DMA; 1. DR SMART; SM00301; DM; 1. DR SUPFAM; SSF82927; Cysteine-rich DNA binding domain, (DM domain); 1. DR SUPFAM; SSF46934; UBA-like; 1. DR PROSITE; PS40000; DM_1; 1. DR PROSITE; PS50809; DM_2; 1. DR Genevisible; Q9NQL9; HS. PE 1: Evidence at protein level; KW Developmental protein; Differentiation; DNA-binding; Metal-binding; KW Nucleus; Reference proteome; Sexual differentiation; Transcription; KW Transcription regulation; Zinc. FT CHAIN 1..472 FT /note="Doublesex- and mab-3-related transcription factor 3" FT /id="PRO_0000277794" FT DOMAIN 249..284 FT /note="DMA" FT /evidence="ECO:0000255" FT DNA_BIND 29..76 FT /note="DM" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00070" FT REGION 89..128 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 155..191 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 430..472 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 92..122 FT /note="Pro residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 155..181 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT VARIANT 164 FT /note="A -> T (in dbSNP:rs10978001)" FT /id="VAR_030591" FT VARIANT 261 FT /note="N -> T (in dbSNP:rs7854621)" FT /id="VAR_030592" FT VARIANT 356 FT /note="G -> V (in dbSNP:rs16927037)" FT /id="VAR_030593" SQ SEQUENCE 472 AA; 51199 MW; BD76C5BE0B100A50 CRC64; MNGYGSPYLY MGGPVSQPPR APLQRTPKCA RCRNHGVLSW LKGHKRYCRF KDCTCEKCIL IIERQRVMAA QVALRRQQAN ESLESLIPDS LRALPGPPPP GDAVAAPQPP PASQPSQPQP PRPAAELAAA AALRWTAEPQ PGALQAQLAK PDLTEERLGD GKSADNTEVF SDKDTDQRSS PDVAKSKGCF TPESPEIVSV EEGGYAVQKN GGNPESRPDS PKCHAEQNHL LIEGPSGTVS LPFSLKANRP PLEVLKKIFP NQKPTVLELI LKGCGGDLVS AVEVLLSSRS SVTGAERTSA EPESLALPSN GHIFEHTLSS YPISSSKWSV GSAFRVPDTL RFSADSSNVV PSPLAGPLQP PFPQPPRYPL MLRNTLARSQ SSPFLPNDVT LWNTMTLQQQ YQLRSQYVSP FPSNSTSVFR SSPVLPARAT EDPRISIPDD GCPFVSKQSI YTEDDYDERS DSSDSRTLNT SS //